Skip to main content

Strensiq Prices, Coupons and Patient Assistance Programs

Strensiq (asfotase alfa) is a member of the miscellaneous metabolic agents drug class and is commonly used for Hypophosphatasia.

Strensiq prices

The cost for Strensiq subcutaneous solution (18 mg/0.45 mL) is around $16,272 for a supply of 5.4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Strensiq price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Subcutaneous Solution Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Strensiq Coupons and Rebates

Strensiq offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Strensiq Alexion OneSource CoPay Program: Eligible commercially insured patients may pay as little as $0 in out-of-pocket costs up to a maximum savings of $15,000 per calendar year; for additional information contact the program at 888-765-4747.

Applies to:
Number of uses:
per prescription per calendar year

Form more information phone: 888-765-4747 or Visit website

Patient Assistance Programs for Strensiq

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: OneSource Patient Support Program from Alexion

Elligibility requirements:
  1. Determined case by case
  2. Determined case by case
  3. FDA-approved diagnosis
  4. Must be treated by US licensed healthcare provider
  5. Insurance benefits, claims assistance, or other reimbursement help is offered. Health care providers must enroll in the REMS program prior to submitting the Patient Assistance Program Application Co-payment assistance, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Strensiq (asfotase alfa) Injection; Subcutaneous

More information please phone: 888-765-4747 Visit Website